中国医药科学Issue(21)：27-32,87,7.
肿瘤转化医学研究进展
Research progress for translational medicine in cancer
摘要
Abstract
Cancer translational research has become a key priority of medical research in developed countries. Cancer translational research has been conducted with support from translational centers with basic research priorities covering cancer genome, gene expression and regulation, tumor microenvironment, anti-cancer mechanism, cancer biomarkers in the field of leukemia, melanoma, lung cancer, prostate cancer, breast cancer, cerebral cancer, colorectal cancer, etc. Translation research has been integrated into the national science and technology plan in China. Disease classification, individualized diagnosis and treatment technologies, and genome technologies have been identified as the priorities of cancer translational research in China, with growing research outputs. Literature metrology, Induction and deduction and aggregate analysis were applied for comprehensive statistics and analysis of key research projects, research priorities and outputs of international cancer translational researches, and the national science and technology plan, research priorities and outputs of cancer translational researches in China. The study provides important data basis and reference for translational medicine development and cancer prevention and control in China based on retrospective statistical analysis of the status quo of cancer translational research in China and abroad.关键词
肿瘤/转化医学/研究进展Key words
Cancer/Translational medicine/Research progress分类
医药卫生引用本文复制引用
田玲,汪楠,陈丹霞,安嘉璐..肿瘤转化医学研究进展[J].中国医药科学,2014,(21):27-32,87,7.基金项目
中国工程院咨询研究项目（2014-XZ-13）。 （）
